APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mefenamic Acid

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mefenamic Acid Industry Growth and Trends Forecast to 2032

19 December 2025126 pages

Choose your research edition.

Industry ResearchMefenamic Acid Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Mefenamic Acid Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Mefenamic Acid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mefenamic Acid Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Mefenamic Acid Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Mefenamic Acid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mefenamic Acid include AA Pharma, ABL Lifecare, Adelco, Agron Remedies, Apotex, Captab, Chemidex Pharma, Daiichi Sankyo and EMS Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mefenamic Acid market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mefenamic Acid market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mefenamic Acid market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mefenamic Acid.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mefenamic Acid market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mefenamic Acid Market by Company

AA Pharma

ABL Lifecare

Adelco

Agron Remedies

Apotex

Captab

Chemidex Pharma

Daiichi Sankyo

EMS Pharma

Esteve

Farmo Quimica

IASIS Pharmaceuticals Hellas

Koa Isei

Mankind

Nisshin Pharmaceutical

Sanofi Aventis

Shinto Organics

Shionogi Pharma

Solitaire Pharmacia

Streuli Pharma,

Wockhardt

Yung Sine

Pfizer

Teva

Mefenamic Acid Segment by Type

Patent

Generic

Mefenamic Acid Segment by Application

On-line

Drug Store

Hospital

Mefenamic Acid Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mefenamic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mefenamic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mefenamic Acid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mefenamic Acid manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mefenamic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Patent Table 2. Major Company of Generic Table 3. Global Mefenamic Acid Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 5. Global Mefenamic Acid Sales Market Share in Volume by Type (2021-2026) Table 6. Global Mefenamic Acid Sales by Type (2021-2026) & (US$ Million) Table 7. Global Mefenamic Acid Sales Market Share in Value by Type (2021-2026) Table 8. Global Mefenamic Acid Price by Type (2021-2026) & (US$/Unit) Table 9. Global Mefenamic Acid Sales by Type (2027-2032) & (K Units) Table 10. Global Mefenamic Acid Sales Market Share in Volume by Type (2027-2032) Table 11. Global Mefenamic Acid Sales by Type (2027-2032) & (US$ Million) Table 12. Global Mefenamic Acid Sales Market Share in Value by Type (2027-2032) Table 13. Global Mefenamic Acid Price by Type (2027-2032) & (US$/Unit) Table 14. North America Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 15. North America Mefenamic Acid Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 17. Europe Mefenamic Acid Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Mefenamic Acid Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 21. Latin America Mefenamic Acid Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Mefenamic Acid Sales by Type (2021-2026) & (US$ Million) Table 24. Mefenamic Acid Industry Trends Table 25. Mefenamic Acid Industry Drivers Table 26. Mefenamic Acid Industry Opportunities and Challenges Table 27. Mefenamic Acid Industry Restraints Table 28. Global Mefenamic Acid Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Mefenamic Acid Revenue Market Share by Company (2021-2026) Table 30. Global Mefenamic Acid Sales by Company (2021-2026) & (K Units) Table 31. Global Mefenamic Acid Sales Share by Company (2021-2026) Table 32. Global Mefenamic Acid Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Mefenamic Acid Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Mefenamic Acid Major Company Production Sites and Headquarters Table 35. Global Mefenamic Acid Company, Product Type & Application Table 36. Global Mefenamic Acid Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Mefenamic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Mefenamic Acid Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Mefenamic Acid Sales by Region (2021-2026) & (K Units) Table 41. Global Mefenamic Acid Sales Market Share in Volume by Region (2021-2026) Table 42. Global Mefenamic Acid Sales by Region (2021-2026) & (US$ Million) Table 43. Global Mefenamic Acid Sales Market Share in Value by Region (2021-2026) Table 44. Global Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Mefenamic Acid Sales by Region (2027-2032) & (K Units) Table 46. Global Mefenamic Acid Sales Market Share in Volume by Region (2027-2032) Table 47. Global Mefenamic Acid Sales by Region (2027-2032) & (US$ Million) Table 48. Global Mefenamic Acid Sales Market Share in Value by Region (2027-2032) Table 49. Global Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Mefenamic Acid Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 52. Global Mefenamic Acid Sales Market Share in Volume by Application (2021-2026) Table 53. Global Mefenamic Acid Sales by Application (2021-2026) & (US$ Million) Table 54. Global Mefenamic Acid Sales Market Share in Value by Application (2021-2026) Table 55. Global Mefenamic Acid Price by Application (2021-2026) & (US$/Unit) Table 56. Global Mefenamic Acid Sales by Application (2027-2032) & (K Units) Table 57. Global Mefenamic Acid Sales Market Share in Volume by Application (2027-2032) Table 58. Global Mefenamic Acid Sales by Application (2027-2032) & (US$ Million) Table 59. Global Mefenamic Acid Sales Market Share in Value by Application (2027-2032) Table 60. Global Mefenamic Acid Price by Application (2027-2032) & (US$/Unit) Table 61. North America Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 62. North America Mefenamic Acid Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 64. Europe Mefenamic Acid Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Mefenamic Acid Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 68. Latin America Mefenamic Acid Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Mefenamic Acid Sales by Application (2021-2026) & (US$ Million) Table 71. AA Pharma Company Information Table 72. AA Pharma Business Overview Table 73. AA Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AA Pharma Mefenamic Acid Product Portfolio Table 75. AA Pharma Recent Development Table 76. ABL Lifecare Company Information Table 77. ABL Lifecare Business Overview Table 78. ABL Lifecare Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. ABL Lifecare Mefenamic Acid Product Portfolio Table 80. ABL Lifecare Recent Development Table 81. Adelco Company Information Table 82. Adelco Business Overview Table 83. Adelco Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Adelco Mefenamic Acid Product Portfolio Table 85. Adelco Recent Development Table 86. Agron Remedies Company Information Table 87. Agron Remedies Business Overview Table 88. Agron Remedies Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Agron Remedies Mefenamic Acid Product Portfolio Table 90. Agron Remedies Recent Development Table 91. Apotex Company Information Table 92. Apotex Business Overview Table 93. Apotex Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Apotex Mefenamic Acid Product Portfolio Table 95. Apotex Recent Development Table 96. Captab Company Information Table 97. Captab Business Overview Table 98. Captab Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Captab Mefenamic Acid Product Portfolio Table 100. Captab Recent Development Table 101. Chemidex Pharma Company Information Table 102. Chemidex Pharma Business Overview Table 103. Chemidex Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Chemidex Pharma Mefenamic Acid Product Portfolio Table 105. Chemidex Pharma Recent Development Table 106. Daiichi Sankyo Company Information Table 107. Daiichi Sankyo Business Overview Table 108. Daiichi Sankyo Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Daiichi Sankyo Mefenamic Acid Product Portfolio Table 110. Daiichi Sankyo Recent Development Table 111. EMS Pharma Company Information Table 112. EMS Pharma Business Overview Table 113. EMS Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. EMS Pharma Mefenamic Acid Product Portfolio Table 115. EMS Pharma Recent Development Table 116. Esteve Company Information Table 117. Esteve Business Overview Table 118. Esteve Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Esteve Mefenamic Acid Product Portfolio Table 120. Esteve Recent Development Table 121. Farmo Quimica Company Information Table 122. Farmo Quimica Business Overview Table 123. Farmo Quimica Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Farmo Quimica Mefenamic Acid Product Portfolio Table 125. Farmo Quimica Recent Development Table 126. IASIS Pharmaceuticals Hellas Company Information Table 127. IASIS Pharmaceuticals Hellas Business Overview Table 128. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio Table 130. IASIS Pharmaceuticals Hellas Recent Development Table 131. Koa Isei Company Information Table 132. Koa Isei Business Overview Table 133. Koa Isei Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Koa Isei Mefenamic Acid Product Portfolio Table 135. Koa Isei Recent Development Table 136. Mankind Company Information Table 137. Mankind Business Overview Table 138. Mankind Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Mankind Mefenamic Acid Product Portfolio Table 140. Mankind Recent Development Table 141. Nisshin Pharmaceutical Company Information Table 142. Nisshin Pharmaceutical Business Overview Table 143. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Nisshin Pharmaceutical Mefenamic Acid Product Portfolio Table 145. Nisshin Pharmaceutical Recent Development Table 146. Sanofi Aventis Company Information Table 147. Sanofi Aventis Business Overview Table 148. Sanofi Aventis Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Sanofi Aventis Mefenamic Acid Product Portfolio Table 150. Sanofi Aventis Recent Development Table 151. Shinto Organics Company Information Table 152. Shinto Organics Business Overview Table 153. Shinto Organics Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Shinto Organics Mefenamic Acid Product Portfolio Table 155. Shinto Organics Recent Development Table 156. Shionogi Pharma Company Information Table 157. Shionogi Pharma Business Overview Table 158. Shionogi Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Shionogi Pharma Mefenamic Acid Product Portfolio Table 160. Shionogi Pharma Recent Development Table 161. Solitaire Pharmacia Company Information Table 162. Solitaire Pharmacia Business Overview Table 163. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Solitaire Pharmacia Mefenamic Acid Product Portfolio Table 165. Solitaire Pharmacia Recent Development Table 166. Streuli Pharma, Company Information Table 167. Streuli Pharma, Business Overview Table 168. Streuli Pharma, Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Streuli Pharma, Mefenamic Acid Product Portfolio Table 170. Streuli Pharma, Recent Development Table 171. Wockhardt Company Information Table 172. Wockhardt Business Overview Table 173. Wockhardt Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Wockhardt Mefenamic Acid Product Portfolio Table 175. Wockhardt Recent Development Table 176. Yung Sine Company Information Table 177. Yung Sine Business Overview Table 178. Yung Sine Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Yung Sine Mefenamic Acid Product Portfolio Table 180. Yung Sine Recent Development Table 181. Pfizer Company Information Table 182. Pfizer Business Overview Table 183. Pfizer Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 184. Pfizer Mefenamic Acid Product Portfolio Table 185. Pfizer Recent Development Table 186. Teva Company Information Table 187. Teva Business Overview Table 188. Teva Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 189. Teva Mefenamic Acid Product Portfolio Table 190. Teva Recent Development Table 191. North America Mefenamic Acid Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. North America Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 193. North America Mefenamic Acid Sales Market Share by Country (2021-2026) Table 194. North America Mefenamic Acid Sales Forecast by Country (2027-2032) & (K Units) Table 195. North America Mefenamic Acid Sales Market Share Forecast by Country (2027-2032) Table 196. North America Mefenamic Acid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. North America Mefenamic Acid Market Size by Country (2021-2026) & (US$ Million) Table 198. North America Mefenamic Acid Market Share by Country (2021-2026) Table 199. North America Mefenamic Acid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. North America Mefenamic Acid Market Share Forecast by Country (2027-2032) Table 201. Europe Mefenamic Acid Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Europe Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 203. Europe Mefenamic Acid Sales Market Share by Country (2021-2026) Table 204. Europe Mefenamic Acid Sales Forecast by Country (2027-2032) & (K Units) Table 205. Europe Mefenamic Acid Sales Market Share Forecast by Country (2027-2032) Table 206. Europe Mefenamic Acid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Europe Mefenamic Acid Market Size by Country (2021-2026) & (US$ Million) Table 208. Europe Mefenamic Acid Market Share by Country (2021-2026) Table 209. Europe Mefenamic Acid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Europe Mefenamic Acid Market Share Forecast by Country (2027-2032) Table 211. Asia-Pacific Mefenamic Acid Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Asia-Pacific Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 213. Asia-Pacific Mefenamic Acid Sales Market Share by Country (2021-2026) Table 214. Asia-Pacific Mefenamic Acid Sales Forecast by Country (2027-2032) & (K Units) Table 215. Asia-Pacific Mefenamic Acid Sales Market Share Forecast by Country (2027-2032) Table 216. Asia-Pacific Mefenamic Acid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Asia-Pacific Mefenamic Acid Market Size by Country (2021-2026) & (US$ Million) Table 218. Asia-Pacific Mefenamic Acid Market Share by Country (2021-2026) Table 219. Asia-Pacific Mefenamic Acid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Asia-Pacific Mefenamic Acid Market Share Forecast by Country (2027-2032) Table 221. Latin America Mefenamic Acid Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 222. Latin America Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 223. Latin America Mefenamic Acid Sales Market Share by Country (2021-2026) Table 224. Latin America Mefenamic Acid Sales Forecast by Country (2027-2032) & (K Units) Table 225. Latin America Mefenamic Acid Sales Market Share Forecast by Country (2027-2032) Table 226. Latin America Mefenamic Acid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 227. Latin America Mefenamic Acid Market Size by Country (2021-2026) & (US$ Million) Table 228. Latin America Mefenamic Acid Market Share by Country (2021-2026) Table 229. Latin America Mefenamic Acid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 230. Latin America Mefenamic Acid Market Share Forecast by Country (2027-2032) Table 231. Middle East and Africa Mefenamic Acid Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 232. Middle East and Africa Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 233. Middle East and Africa Mefenamic Acid Sales Market Share by Country (2021-2026) Table 234. Middle East and Africa Mefenamic Acid Sales Forecast by Country (2027-2032) & (K Units) Table 235. Middle East and Africa Mefenamic Acid Sales Market Share Forecast by Country (2027-2032) Table 236. Middle East and Africa Mefenamic Acid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 237. Middle East and Africa Mefenamic Acid Market Size by Country (2021-2026) & (US$ Million) Table 238. Middle East and Africa Mefenamic Acid Market Share by Country (2021-2026) Table 239. Middle East and Africa Mefenamic Acid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 240. Middle East and Africa Mefenamic Acid Market Share Forecast by Country (2027-2032) Table 241. Key Raw Materials Table 242. Raw Materials Key Suppliers Table 243. Mefenamic Acid Distributors List Table 244. Mefenamic Acid Customers List Table 245. Research Programs/Design for This Report Table 246. Authors List of This Report Table 247. Secondary Sources Table 248. Primary Sources List of Figures Figure 1. Mefenamic Acid Image Figure 2. Global Mefenamic Acid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mefenamic Acid Market Size (2021-2032) & (US$ Million) Figure 4. Global Mefenamic Acid Sales (2021-2032) & (K Units) Figure 5. Patent Image Figure 6. Global Patent Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Image Figure 8. Global Generic Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Mefenamic Acid Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Mefenamic Acid Market Share by Type 2025 VS 2032 Figure 11. North America Mefenamic Acid Sales Market Share in Volume by Type in 2025 Figure 12. North America Mefenamic Acid Sales Market Share in Value by Type in 2025 Figure 13. Europe Mefenamic Acid Sales Market Share in Volume by Type in 2025 Figure 14. Europe Mefenamic Acid Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Mefenamic Acid Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Mefenamic Acid Sales Market Share in Value by Type in 2025 Figure 17. Latin America Mefenamic Acid Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Mefenamic Acid Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Mefenamic Acid Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Mefenamic Acid Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Mefenamic Acid Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. On-line Image Figure 24. Global On-line Sales YoY Growth (2021-2032) & (K Units) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Mefenamic Acid Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Mefenamic Acid Market Share by Application 2025 VS 2032 Figure 31. North America Mefenamic Acid Sales Market Share in Volume by Application in 2025 Figure 32. North America Mefenamic Acid Sales Market Share in Value by Application in 2025 Figure 33. Europe Mefenamic Acid Sales Market Share in Volume by Application in 2025 Figure 34. Europe Mefenamic Acid Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Mefenamic Acid Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Mefenamic Acid Sales Market Share in Value by Application in 2025 Figure 37. Latin America Mefenamic Acid Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Mefenamic Acid Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Mefenamic Acid Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Mefenamic Acid Sales Market Share in Value by Application in 2025 Figure 41. North America Mefenamic Acid Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Mefenamic Acid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Mefenamic Acid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Mefenamic Acid Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Mefenamic Acid Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Mefenamic Acid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Mefenamic Acid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Mefenamic Acid Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Mefenamic Acid Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Mefenamic Acid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Mefenamic Acid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Mefenamic Acid Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Mefenamic Acid Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Mefenamic Acid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Mefenamic Acid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Mefenamic Acid Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Mefenamic Acid Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Mefenamic Acid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Mefenamic Acid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Mefenamic Acid Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Mefenamic Acid Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Mefenamic Acid Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • On-line
  • Drug Store
  • Hospital
Companies covered
  • AA Pharma
  • ABL Lifecare
  • Adelco
  • Agron Remedies
  • Apotex
  • Captab
  • Chemidex Pharma
  • Daiichi Sankyo
  • EMS Pharma
  • Esteve
  • Farmo Quimica
  • IASIS Pharmaceuticals Hellas
  • Koa Isei
  • Mankind
  • Nisshin Pharmaceutical
  • Sanofi Aventis
  • Shinto Organics
  • Shionogi Pharma
  • Solitaire Pharmacia
  • Streuli Pharma,
  • Wockhardt
  • Yung Sine
  • Pfizer
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mefenamic Acid Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mefenamic Acid Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mefenamic Acid Market by Type
  6. 1.3.1 Patent
  7. 1.3.2 Generic
  8. 1.4 Global Mefenamic Acid Market Size by Type
  9. 1.4.1 Global Mefenamic Acid Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Mefenamic Acid Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Mefenamic Acid Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Mefenamic Acid Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Mefenamic Acid Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Mefenamic Acid Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Mefenamic Acid Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Mefenamic Acid Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mefenamic Acid Industry Trends
  2. 2.2 Mefenamic Acid Industry Drivers
  3. 2.3 Mefenamic Acid Industry Opportunities and Challenges
  4. 2.4 Mefenamic Acid Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mefenamic Acid Revenue (2021-2026)
  2. 3.2 Global Top Players by Mefenamic Acid Sales (2021-2026)
  3. 3.3 Global Top Players by Mefenamic Acid Price (2021-2026)
  4. 3.4 Global Mefenamic Acid Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mefenamic Acid Major Company Production Sites & Headquarters
  6. 3.6 Global Mefenamic Acid Company, Product Type & Application
  7. 3.7 Global Mefenamic Acid Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mefenamic Acid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mefenamic Acid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mefenamic Acid Tier 1, Tier 2, and Tier 3
4 Mefenamic Acid Regional Status and Outlook
  1. 4.1 Global Mefenamic Acid Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mefenamic Acid Historic Market Size by Region
  3. 4.2.1 Global Mefenamic Acid Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mefenamic Acid Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mefenamic Acid Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mefenamic Acid Forecasted Market Size by Region
  7. 4.3.1 Global Mefenamic Acid Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mefenamic Acid Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mefenamic Acid Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mefenamic Acid by Application
  1. 5.1 Mefenamic Acid Market by Application
  2. 5.1.1 On-line
  3. 5.1.2 Drug Store
  4. 5.1.3 Hospital
  5. 5.2 Global Mefenamic Acid Market Size by Application
  6. 5.2.1 Global Mefenamic Acid Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Mefenamic Acid Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Mefenamic Acid Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Mefenamic Acid Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Mefenamic Acid Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Mefenamic Acid Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Mefenamic Acid Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Mefenamic Acid Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AA Pharma
  2. 6.1.1 AA Pharma Company Information
  3. 6.1.2 AA Pharma Business Overview
  4. 6.1.3 AA Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AA Pharma Mefenamic Acid Product Portfolio
  6. 6.1.5 AA Pharma Recent Developments
  7. 6.2 ABL Lifecare
  8. 6.2.1 ABL Lifecare Company Information
  9. 6.2.2 ABL Lifecare Business Overview
  10. 6.2.3 ABL Lifecare Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ABL Lifecare Mefenamic Acid Product Portfolio
  12. 6.2.5 ABL Lifecare Recent Developments
  13. 6.3 Adelco
  14. 6.3.1 Adelco Company Information
  15. 6.3.2 Adelco Business Overview
  16. 6.3.3 Adelco Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Adelco Mefenamic Acid Product Portfolio
  18. 6.3.5 Adelco Recent Developments
  19. 6.4 Agron Remedies
  20. 6.4.1 Agron Remedies Company Information
  21. 6.4.2 Agron Remedies Business Overview
  22. 6.4.3 Agron Remedies Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Agron Remedies Mefenamic Acid Product Portfolio
  24. 6.4.5 Agron Remedies Recent Developments
  25. 6.5 Apotex
  26. 6.5.1 Apotex Company Information
  27. 6.5.2 Apotex Business Overview
  28. 6.5.3 Apotex Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Apotex Mefenamic Acid Product Portfolio
  30. 6.5.5 Apotex Recent Developments
  31. 6.6 Captab
  32. 6.6.1 Captab Company Information
  33. 6.6.2 Captab Business Overview
  34. 6.6.3 Captab Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Captab Mefenamic Acid Product Portfolio
  36. 6.6.5 Captab Recent Developments
  37. 6.7 Chemidex Pharma
  38. 6.7.1 Chemidex Pharma Company Information
  39. 6.7.2 Chemidex Pharma Business Overview
  40. 6.7.3 Chemidex Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chemidex Pharma Mefenamic Acid Product Portfolio
  42. 6.7.5 Chemidex Pharma Recent Developments
  43. 6.8 Daiichi Sankyo
  44. 6.8.1 Daiichi Sankyo Company Information
  45. 6.8.2 Daiichi Sankyo Business Overview
  46. 6.8.3 Daiichi Sankyo Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Daiichi Sankyo Mefenamic Acid Product Portfolio
  48. 6.8.5 Daiichi Sankyo Recent Developments
  49. 6.9 EMS Pharma
  50. 6.9.1 EMS Pharma Company Information
  51. 6.9.2 EMS Pharma Business Overview
  52. 6.9.3 EMS Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 EMS Pharma Mefenamic Acid Product Portfolio
  54. 6.9.5 EMS Pharma Recent Developments
  55. 6.10 Esteve
  56. 6.10.1 Esteve Company Information
  57. 6.10.2 Esteve Business Overview
  58. 6.10.3 Esteve Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Esteve Mefenamic Acid Product Portfolio
  60. 6.10.5 Esteve Recent Developments
  61. 6.11 Farmo Quimica
  62. 6.11.1 Farmo Quimica Company Information
  63. 6.11.2 Farmo Quimica Business Overview
  64. 6.11.3 Farmo Quimica Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Farmo Quimica Mefenamic Acid Product Portfolio
  66. 6.11.5 Farmo Quimica Recent Developments
  67. 6.12 IASIS Pharmaceuticals Hellas
  68. 6.12.1 IASIS Pharmaceuticals Hellas Company Information
  69. 6.12.2 IASIS Pharmaceuticals Hellas Business Overview
  70. 6.12.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio
  72. 6.12.5 IASIS Pharmaceuticals Hellas Recent Developments
  73. 6.13 Koa Isei
  74. 6.13.1 Koa Isei Company Information
  75. 6.13.2 Koa Isei Business Overview
  76. 6.13.3 Koa Isei Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Koa Isei Mefenamic Acid Product Portfolio
  78. 6.13.5 Koa Isei Recent Developments
  79. 6.14 Mankind
  80. 6.14.1 Mankind Company Information
  81. 6.14.2 Mankind Business Overview
  82. 6.14.3 Mankind Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Mankind Mefenamic Acid Product Portfolio
  84. 6.14.5 Mankind Recent Developments
  85. 6.15 Nisshin Pharmaceutical
  86. 6.15.1 Nisshin Pharmaceutical Company Information
  87. 6.15.2 Nisshin Pharmaceutical Business Overview
  88. 6.15.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Nisshin Pharmaceutical Mefenamic Acid Product Portfolio
  90. 6.15.5 Nisshin Pharmaceutical Recent Developments
  91. 6.16 Sanofi Aventis
  92. 6.16.1 Sanofi Aventis Company Information
  93. 6.16.2 Sanofi Aventis Business Overview
  94. 6.16.3 Sanofi Aventis Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sanofi Aventis Mefenamic Acid Product Portfolio
  96. 6.16.5 Sanofi Aventis Recent Developments
  97. 6.17 Shinto Organics
  98. 6.17.1 Shinto Organics Company Information
  99. 6.17.2 Shinto Organics Business Overview
  100. 6.17.3 Shinto Organics Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Shinto Organics Mefenamic Acid Product Portfolio
  102. 6.17.5 Shinto Organics Recent Developments
  103. 6.18 Shionogi Pharma
  104. 6.18.1 Shionogi Pharma Company Information
  105. 6.18.2 Shionogi Pharma Business Overview
  106. 6.18.3 Shionogi Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Shionogi Pharma Mefenamic Acid Product Portfolio
  108. 6.18.5 Shionogi Pharma Recent Developments
  109. 6.19 Solitaire Pharmacia
  110. 6.19.1 Solitaire Pharmacia Company Information
  111. 6.19.2 Solitaire Pharmacia Business Overview
  112. 6.19.3 Solitaire Pharmacia Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Solitaire Pharmacia Mefenamic Acid Product Portfolio
  114. 6.19.5 Solitaire Pharmacia Recent Developments
  115. 6.20 Streuli Pharma,
  116. 6.20.1 Streuli Pharma, Company Information
  117. 6.20.2 Streuli Pharma, Business Overview
  118. 6.20.3 Streuli Pharma, Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Streuli Pharma, Mefenamic Acid Product Portfolio
  120. 6.20.5 Streuli Pharma, Recent Developments
  121. 6.21 Wockhardt
  122. 6.21.1 Wockhardt Company Information
  123. 6.21.2 Wockhardt Business Overview
  124. 6.21.3 Wockhardt Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Wockhardt Mefenamic Acid Product Portfolio
  126. 6.21.5 Wockhardt Recent Developments
  127. 6.22 Yung Sine
  128. 6.22.1 Yung Sine Company Information
  129. 6.22.2 Yung Sine Business Overview
  130. 6.22.3 Yung Sine Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Yung Sine Mefenamic Acid Product Portfolio
  132. 6.22.5 Yung Sine Recent Developments
  133. 6.23 Pfizer
  134. 6.23.1 Pfizer Company Information
  135. 6.23.2 Pfizer Business Overview
  136. 6.23.3 Pfizer Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Pfizer Mefenamic Acid Product Portfolio
  138. 6.23.5 Pfizer Recent Developments
  139. 6.24 Teva
  140. 6.24.1 Teva Company Information
  141. 6.24.2 Teva Business Overview
  142. 6.24.3 Teva Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Teva Mefenamic Acid Product Portfolio
  144. 6.24.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Mefenamic Acid Sales by Country
  2. 7.1.1 North America Mefenamic Acid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mefenamic Acid Sales by Country (2021-2026)
  4. 7.1.3 North America Mefenamic Acid Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mefenamic Acid Market Size by Country
  6. 7.2.1 North America Mefenamic Acid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mefenamic Acid Market Size by Country (2021-2026)
  8. 7.2.3 North America Mefenamic Acid Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mefenamic Acid Sales by Country
  2. 8.1.1 Europe Mefenamic Acid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mefenamic Acid Sales by Country (2021-2026)
  4. 8.1.3 Europe Mefenamic Acid Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mefenamic Acid Market Size by Country
  6. 8.2.1 Europe Mefenamic Acid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mefenamic Acid Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mefenamic Acid Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mefenamic Acid Sales by Country
  2. 9.1.1 Asia-Pacific Mefenamic Acid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mefenamic Acid Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mefenamic Acid Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mefenamic Acid Market Size by Country
  6. 9.2.1 Asia-Pacific Mefenamic Acid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mefenamic Acid Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mefenamic Acid Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mefenamic Acid Sales by Country
  2. 10.1.1 South America Mefenamic Acid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mefenamic Acid Sales by Country (2021-2026)
  4. 10.1.3 South America Mefenamic Acid Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mefenamic Acid Market Size by Country
  6. 10.2.1 South America Mefenamic Acid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mefenamic Acid Market Size by Country (2021-2026)
  8. 10.2.3 South America Mefenamic Acid Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mefenamic Acid Sales by Country
  2. 11.1.1 Middle East and Africa Mefenamic Acid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mefenamic Acid Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mefenamic Acid Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mefenamic Acid Market Size by Country
  6. 11.2.1 Middle East and Africa Mefenamic Acid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mefenamic Acid Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mefenamic Acid Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mefenamic Acid Value Chain Analysis
  2. 12.1.1 Mefenamic Acid Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mefenamic Acid Production Mode & Process
  7. 12.2 Mefenamic Acid Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mefenamic Acid Distributors
  10. 12.2.3 Mefenamic Acid Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst